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THE TREATMENT OF CANCER 
By JOHN McKENDRICK 
Based on a Dissertation read before the Royal 
Medical Society on Friday, 16th January 1959. 
AN overall view of the adequacy of the treatment of cancer at the moment 
presents a very dismal picture. To be satisfactory this treatment must mean 
cure, but until the cause or causes of cancer are known this will seldom be 
achieved. 
The possible means of treatment available are :-Surgery, Radiotherapy. 
Chemotherapy, Serotherapy and Psychobiological methods. Prophylactic 
measures designed to prevent a person from getting cancer are, of course, of 
great importance also. 
Let us first consider Surgery. The human race has been faced with the 
problem of cancer for thousands of years. Carcinoma of the breast was 
described by the Egyptian surgeon Imhotep in the year 3000 B.c. It is 
mentioned in the papyrus Ebers. of the 16th century B.C. and in the remnants 
of the literature of India and Persia. In those ancient times the mainstay of 
treatment was excision and caustics and in A.D. 180 Leonides of Alexandria 
was dissecting out breast cancers extensively, cutting through healthy tissue 
with knife and cutOeryessentially the same technique as is used to-day. 
In no other branch of Therapeutics has so little advance been made against 
a disease known for so long. It is a measure of our ability to conquer the 
neoplastic process that such a crude and primitive procedure as surgical 
excision should be the main, and in some cases the only, radical weapon at 
our disposal. 
Surgery is successful in curing cancer in so far as it can get right down 
to the "roots" and remove the growth, plus the immediately surrounding 
tissues, where there will be a small number of outlying cancer cells. It is thus 
effective in removing a superficial tumour where no metastases have occurred, 
such as one of the skin, uterine cervix, bladder, rectum and a few cases of 
cancer of the thyroid and parotid glands. In other cases a significant remis-
sion may be obtained. A surgical procedure may also be effective in relieving 
obstruction or pressure, controlling infection or stopping persistent bleeding. 
But, on the whole, Surgery is not a satisfactory method of treatment, and its 
possible advantages must be weighed against its many shortcomings, which 
include: mutilation, inadequate removal of cancer cells, further spread of 
cancer cells, disturbance of the normal physiological mechanisms of the body 
and possibly death. 
There is now an increasing pressure on the surgeon to "do something 
about cancer." Articles in lay magazines, the "education" spread forth by 
the satanic T.V. set, reports of ultraradical operations and the patient's 
natural desire for cure make it difficult to tell those with certain types of 
cancer that they cannot be helped by operation. Consideration must be given 
to the fact that the "something" may do more harm than good. The persistent 
failure of ultraradical surgery to arrest cancers of high malignancy and the 
devastating side-effects of these operations make it obvious that it is time to 
give first thought to the patient as a whole, and to develop operations which 
control the malignant process as well as possible. but with the minimum 
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deformity and impairment of function. There is some place for radical opera-
tions, especially in treatment of cancer of the head and neck, rectum, colon 
and cervix, but the initial wave of enthusiasm is now being replaced with 
more caution. Definite rules must be followed in their procedure: they 
should only be done by specialists, there must be proper selection of patients, 
at no time should cancer tissue be cut across and the possibility of seeding 
into the wound allowed to occur, routes of spread must be sealed off as early 
as possible, the wound should be washed before closure, possibly using cyto-
toxins and in the future there may be a possibility of administering cytotoxins 
parenterally before, during and after the operation. 
Surgery by itself, however, has probably reached the stage at which no 
great advance in method can be expected, but there is a field for its possible 
use in conjunction with other methods. 
X-rays were discovered by Roentgen in 1895 and have been used in 
therapy ever since. The gamma rays emitted by Radium are most commonly 
used since they have much the greatest penetrating power. Many advances 
have been made recently in this form of therapy, and its main advantage is 
that it does not involve the possibility of cutting into malignant tissue. Critical 
assessment of the results obtained, however, indicates that there is little justifi-
cation for complacency. There may result increased comfort and palliation, 
but the long-term or "cure" rates have shown little improvement. 
Radiotherapy is especially effective against actively dividing cells, but 
normal cells are also damaged to a greater or less extent and not all cancers 
are affected by it. 
In general the conservative optimal dosage to all organs is 6000r delivered 
over a period of time depending on several clinical factors, but most tumours 
have a wide range of lethal dose. Surface applicators containing the Radium 
can be moulded to a part of the body and applicators can be placed in hollow 
organs such as the uterus. Interstitial irradiation is obtained by means of 
Radium or radioactive Cobalt needles, Radon seeds or radioactive Tantalum 
wire coated with Platinum to absorb the Beta rays. Such methods are effective 
against superficial or localised growths. For deeper growths the teleradium 
or radium beam treatment can be used, but this is usually less successful 
since the risk to surrounding normal tissue is much increased. The best effects 
are obtained with carcinoma of the cervix and some lympho-sarcomas. 
For many years Radiotherapy has been used only for palliation, but it 
can be curative when properly applied to certain types of cancer. It is now 
used in the treatment of seminoma of the testis, dysgerminoma of the ovary, 
medulloblastomas and Iymphoepitheliomas of the throat. The results are 
not good, but are better than those obtained by methods previously used in 
these cases. 
There is a growing necessity for teamwork between surgeons and radio-
therapists to ensure maximum chance of cure with the best functional results. 
Some tumours are now amenable to treatment using either or both surgery 
and radiotherapy, and radiotherapy is an alternative to surgery in treating 
carcinomas of the skin, mouth and lip, cervix and bladder. 
Sources of super-voltage therapy are now available, including the super-
voltage X-ray machine, betatron, thoratron. the linear accelerator and high 
specific intensity radioactive sources of Cobalt 60 and Caesium 130, by which 
means sources of radiation are provided which allow a homogeneous dose 
to be delivered at a definite volume. Radiation can now be produced with 
a shorter Z D Y H  , H Q J W K  and higher energy which penetrates more deeply into 
the tissues, with less damage to the intervening normal tissues and portals can 
be shaped to shield the normal tissue and allow accurate high dosage to small 
volumes. 
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The emphasis in Radiotherapy is tending to shift to the radiobiological 
aspects of the tumour and attempts are being made to render malignant 
tissues more susceptible to irradiation without increasing the vulnerability of 
the normal tissues. Biochemical methods involving thyroid hormone, adrcno-
corticoids, oestrogens, androgens and oxygen alter the intracellular homeo-
stasis and so enhance the effects of irradiation. Radiotherapy has also been 
used along with other drugs, such as Synkavit, nitrogen mustards and 
Actinomycin D. 
Artificial radioactive isotopes were first used therapeutically in 1936 and 
since then a wide variety of applications have been developed. They have not 
proved so beneficial as was initially expected, though they can be effective 
in certain forms of malignancy. Radioactive Phosphorus was the first to be 
used-this localises in body tissues which have a high exchangeable phos-
phorus content (especially bone), a high metabolic rate and a rapid rate of 
cellular reproduction. It is still used in the treatment of polycythaemia vera 
and chronic lymphatic leukaemia. Strontium 90 applicators can be used to 
irradiate superficial tumours of the eyelids. conjunctivae and cornea. Colloidal 
chromic phosphate, radioyttrium and radiogold are now widely used for the 
control of malignant effusions and are being administered interstitially in 
cases of carcinoma of the prostate after surgical removal of as much of the 
tumour as possible. Good results have been reported following intracavitary 
or interstitial application of Cobalt 60 in a variety of tumours, such as carci-
noma of the bladder and uterus, but its use as a gamma source of telethera-
peutic units of deep penetration is currently of most interest. Recent studies 
of autoimmunisation indicate that it may be possible to deliver a radiation 
dose to tumours using radioactive antibodies. Neutron fission therapy in 
glioblastoma multiforme is another interesting approach. Boron 10 is 
administered and the patient is subjected to slow neutrons which cause the 
Boron to disintegrate into Lithium and alpha particles within the tumour. 
But it is too early to predict the place of this work in cancer therapy. Radio-
active isotopes have still only a very limited use, but they constitute a fruitful 
field for research. 
Chemotherapy, as a rational means of treating cancer, has only recently 
been developed, but various diverse agents have been used at different times 
in the past, including belladonna, aconite, mercury, antimony, arsenic and 
potions of animal, vegetable and other ingredients brewed under the charm 
of magical incantations. A popular application in this country during the 
15th century was a powder made by burning together sulphur, lead and 
"arnement" (a black powder used for making ink) which was applied to the 
ulcerated surface after it had first been washed with the urine of a male child. 
In the 18th century live toads were bound over the diseased part and left 
there for 24 hours. Live kittens. puppies and fowls, pigeons split lengthwise, 
minced lizards and pounded crabs have all had their vogue. In 1802 a remedy 
was published which was to dry the corns and pairings from the feet of an 
uncastrated horse, beat this to a powder and take as much as would lie on a 
sixpence in a glass of white wine night and morning. Medicine, greatly helped 
by Science, has made significant advances since then-or so we would hope. 
In the past few years many new chemicals have been developed for use 
in the treatment of cancer, but in actual practice the therapeutic gains have 
been very little. No chemotherapeutic agent has been shown to cure a patient 
of cancer, though in some cases drugs may relieve symptoms, reduce time 
spent in hospital, prolong life and increase the possibility of eventual cure 
by other means. 
As with other methods of treatment, the efficacy of Chemotherapy depends 
on the differential sensitivity of tumourous as against normal tissue. and 
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there is often a slight margin of safety between the effective dosage and that 
which will cause degeneration of the haemopoietic system and the develop-
ment of an aplastic bone-marrow. 
The chemicals which are available can be divided broadly into three 
groups: the alkylating agents .. W K H  antimetabolites and a small miscellaneous 
group mainly of vegetable ongm. 
The alkylating agents comprise a vast number of drugs, including "TEM," 
"Myleran," "Tretamine," 'Chlorambucil" and the Q L W U R J H Q  P X V W D U G V   Studies 
on similar substances have proved that they are effective on certam malignant 
tumours of mice, human carcinoma of the breast and some C.N.S. tumours. 
However, nitrogen mustards and other alkylating agents are used mainly in 
the treatment of the chronic leukaemias and widely disseminated Hodgkin's 
disease, and may produce remissions of several months or even a year. Direct 
instillation of nitrogen mustards may decrease or eliminate reaccumulation of 
malignant effusions and they are of some benefit in the terminal stages of 
bronchogenic carcinoma, especially of the small cell type. The indications 
for using nitrogen mustards include: radioresistance, severe radiation sick-
ness, exhaustion of the skin portals, intractable systemic symptoms, acute 
mediastinal compression, advanced disease and metastatic lesions not amen-
able to X-ray therapy. 
Antimetabolites such as "Aminopterine," "6-Mercaptopurine," 'Pyri-
methamine" and "Urethane" are used mainly in the management of acute 
leukaemia. However, the length of remission obtained is very variable, and 
these drugs are liable to have serious toxic effects, such as damage to the 
bone-marrow and alimentary epithelium, and the neoplastic cells are able to 
develop resistance to them. 
The miscellaneous group have two things in common-none of them is 
of great value and most of them are still undergoing trial. "Colcemid" may 
have some success against chronic myeloid leukaemia. Actinomycin D is 
effective to some extent in the treatment of soft tissue sarcomas and some 
epithelial tumours. Actinomycin C gets a response in a few cases of Hodgkin's 
disease. Cyanocobalamine has been recommended for disseminated neuro-
blastoma, particularly in infants. 
It has been suspected since about 1925 that Insulin may cause some inhibi-
tion in the growth of malignant tissue. Glucagon also has this action and 
the two combined give an even greater carcinostatic effect. Experiments 
have been done on rats, and the greatest limitation seems to be that the 
retardation of tumour growth persists only during the period of administration. 
These investigations must be carried much further before they can have any 
application to treatment in humans. 
A new method of using drug treatment is now being tried. In the case 
of certain tumours the blood supply to the tumour-bearing area is isolated. 
and by using a pump oxygenator system the viability of the limb Qr organ 
can be maintained while at the same time it can be perfused with high con-
centrations of chemotherapeutic agents sufficient to destroy the cancer cells but 
unable to destroy the normal host tissue cells. The temporary isolation of the 
blood supply prevents the passage of the agent into the bloodstream and thus 
prevents bone-marrow depression. 
Better results may be obtained using a combination of drugs, or of drugs 
with radiotherapy. The normal physiological activity of the cancer cell is 
disturbed either by direct alkylation of cell constituents. blocking essential 
metabolic pathways, interfering with the normal enzymatic reactions, altering 
the hormal milieu of the cell or by the effect on the mitotic activity and 
chromosomal structure produced by ionising radiation. Thus different 
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methods of treatment may have a synergistic effect when applied i n  
combination. 
The use of specific hormones is another aspect of Chemotherapy, and com-
bined with endocrine ablation therapy has proved of value in the palliative 
treatment of breast and prostatic carcinomas. Oestrogens may favourably 
affect the primary growth on the soft tissue metastases and also relieve the 
pain of bony metastases. They should be reserved for inoperable breast cancers 
in women who are at least 5 years past the menopause, and for prostatic 
cancers when the testes are known to be producing androgens. Androgens 
are of little use and may in fact exacerbate tumour growth, probably due 
to conversion of oestrogens. About 50% of mammary carcinomas are 
oestrogen dependent and will respond favourably to removal of endogenous 
sources of oestrogens, such as the ovaries, adrenals and hypophysis. 
Serotherapy has yet to become a practical procedure and may not do 
do so until the cause or causes of cancer have been better elucidated. There 
is now much research into the theory involving a transmissable viral-like 
particle found in the cell cytoplasm. A serum specific to the virus of avian 
myeloblastic leukosis has been developed and this is able to neutralise the 
infectivity of the virus. Research into the application of this theory to 
treatment has, as yet, produced equivocal results. 
Psychobiology is another way of regarding the chemical, nervous, hor-
monal or electromagnetic environment of the cancer cell. Since both the 
host and a cancer draw on a common nutritional substrate and share a 
common vascular supply, it seems desirable that attention should be given 
to the metabolic equilibrium and growth partition which exists between 
them. This contest can be turned in favour of the host cells by spontaneous 
activity of the body itself without any apparent assistance, but the phenomenon 
of spontaneous regression is still a complete mystery. Perhaps some people 
are able to develop antibodies against a possible cancer virus or have hor-
monal changes which lead to death of the malignant cells. Such possibilities 
are all remote. but the fact that the body sometimes knows how to kill 
cancer may some day show the way to a method by which all cancers can 
be killed. 
In general, treatment should be directed at the patienHumour system 
and not at the tumour in imaginary isolation. The difiicult question of the 
relationship between stress and host resistance has been slightly clarified 
recently and it appears that an unavoidable accompaniment of the disturbed 
physiology of the stressed organism is diminished resistance to disease. 
including cancer. A definite inverse correlation between psychotic with-
drawal from reality and the incidence and progression of malignant tumours 
has been Q R W H G  in withdrawn patients' response to therapy, if any is required 
at all, is usually excellent and they can expect much longer remissions than 
their anxiety-ridden fellow sufferers. This is added proof that cancer is not 
a predictable, irreversible process and that every effort should be made to 
improve the patients' emotional state. Confidence in the healing ability of 
something or someone has proved curative in many organic lesions, includ-
ing cancer. 
Of supreme importance in the treatment of cancer is the physician who 
meets the patient as an individual with a problem, whether he be suffering 
from cancer or cancerophobia. This latter is a powerful new disease, 
insidious. contagious and crippling and its increasing incidence is greatly 
contributed to by the medical propagandists who have in the past consistently 
used the weapon of fear in their relations with the public. The question 
arises whether or not to educate people about cancer. and since "scare them 
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out of their wits" is nearer what actually happens, it is certainly undesirable. 
Instilling knowledge into people about cancer. will probably have the opposite 
effect to that desired, will do no good to the1r mental health and may cause 
great suffering. Stimulated E \  I H D U  we may find Man U H Y H U W L Q J  to the time 
of the ancient Egyptians and d1vertmg all his efforts to the bmldmg of tombs. 
Some education about cancer is necessary-that regarding avoidance of 
those factors which are known to be liable to initiate a cancerous growth. 
Some of these are occupational hazards such as tar and aniline dyes and 
assorted factors such as X-radiation, cigarettes, clay-pipes and atomic bombs. 
Gallstones and chronic gastritis should be promptly treated, as should 
lesions with a definite malignant potentiality such as some bone growths, 
papillomatous growths (especially of the large bowel), some glandular hyper-
plasias and hydatidiform moles. But there is a danger in the so-called 
"prophylactic operation" which may, in fact, over a large number of cases 
cause more deaths than would have resulted had the operations not been 
done. 
An important new development in prophylactic treatment is the routine 
examination of cervical smears when women over about 30 are under 
examination for some other gynaecological complaint. Many "carcinoma 
in situ" may be detected by this means, and it is reckoned that     of 
these will eventually progress if not treated at this stage, though actual 
symptoms may not be experienced for about ten years and the diagnosis not 
made for a further five years. Also in the case of a persistent pneumonia, 
especially in a middle-aged male, it is advisable to do chest X-rays, broncho-
scopy and examination of the sputum for malignant cells. These, at the 
moment, are the only two routine procedures which can be recommended, 
since the technique is simple, the patient need not be unduly disturbed and 
the number of cases in which a diagnosis of malignancy is made will be 
relatively high. Routine medical check-ups on healthy individuals involving 
thorough physical examination, X-rays of the whole body, bronchoscopy, 
gastroscopy, cystoscopy, proctoscopy, colposcopy, etc., etc., etc., as are often 
recommended, should in fact be discouraged since the procedure is more 
likely to breed neuroticism than complacency. 
At the moment surgeons and radiotherapists are well aware of the many 
defects in their particular forms of treatment and, along with the other 
members of the team, these and many other difficulties are being attacked 
with optimism and enthusiasm, and so: "0 Tempus Futurum. te magna 
spe expectamus!" 
